By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Motus Therapeutics 

500 Boylston Street, 11th Floor

Boston  Massachusetts  02116  U.S.A.
Phone: 857-264-4280 Fax: 857-264-4299


SEARCH JOBS

Motus is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases. Our lead product candidate, relamorelin, is a potent, best-in-class, Phase 2 ghrelin agonist for the treatment of diabetic gastroparesis, a GI complication of diabetes, and other GI functional disorders. We believe this product candidate has the potential to treat gastrointestinal conditions for which there are currently limited therapeutic options. We believe that ghrelin is a compelling target because of its critical role in regulating GI function and metabolism, and that peptide therapeutics are well suited for activating this target.

YEAR FOUNDED:

2008

LEADERSHIP:

Founder: Bart Henderson

CEO: Keith M. Gottesdiener

CMO: Fred T. Fiedorek

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@motustx.com
Ownership: Private

Web Site: Motus
Employees:
Symbol: 
 









Company News
//-->